# DEVELOPMENT OF A NOVEL PLASMA PROTEIN BIOMARKER PANEL FOR A RADIATION/NUCLEAR TRIAGE BIODOSIMETRY DEVICE (RAPID RAD DX)

> **NIH NIH N01** · SRI INTERNATIONAL · 2024 · $1,999,782

## Abstract

Develop a protein-based biomarker multiplexed lateral flow assay (LFA) as a rapid qualitative radiation/nuclear biodosimetry triage device (RapidRadDx) that can distinguish between exposed and unexposed individuals in a mass-casualty ionizing radiation (IR) incident as early as 24 hours post-exposure and continuing out to 72 hours. The protein biomarker assay is intended for field use, detecting a novel plasma-soluble biomarker panel in small volumes of capillary blood samples obtained using minimally invasive finger pricks.

## Key facts

- **NIH application ID:** 11165566
- **Project number:** 75N93024C00006-0-9999-1
- **Recipient organization:** SRI INTERNATIONAL
- **Principal Investigator:** HUA LIN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $1,999,782
- **Award type:** —
- **Project period:** 2024-03-01 → 2025-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11165566

## Citation

> US National Institutes of Health, RePORTER application 11165566, DEVELOPMENT OF A NOVEL PLASMA PROTEIN BIOMARKER PANEL FOR A RADIATION/NUCLEAR TRIAGE BIODOSIMETRY DEVICE (RAPID RAD DX) (75N93024C00006-0-9999-1). Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/grant/nih/11165566. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*